Empresa RLS Global AB (publ) Nasdaq Stockholm
Acciones
SE0005190725
Farmacéuticos
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Director of Finance/CFO | 64 | 22/08/23 | |
Magnus Nolmark
COO | Chief Operating Officer | 59 | 01/01/21 |
Susanne Olausson
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 71 | 01/08/12 | |
Director/Board Member | 63 | 01/08/17 | |
Anders Edvell
BRD | Director/Board Member | 55 | 01/01/23 |
Roland Frösing
CEO | Chief Executive Officer | 64 | 01/01/21 |
Lars Johansson
CHM | Chairman | 58 | 01/01/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 79 874 705 | 41 780 367 ( 52,31 %) | 0 | 52,31 % |
Información de la empresa
Varia. 1 de ene. | Capi. | |
---|---|---|
+30,38 % | 684 mil M | |
+26,51 % | 568 mil M | |
-4,36 % | 361 mil M | |
+19,30 % | 329 mil M | |
+3,73 % | 284 mil M | |
+16,70 % | 240 mil M | |
+8,78 % | 208 mil M | |
-7,93 % | 200 mil M | |
+7,68 % | 166 mil M |